Otsuka Holdings
4578.T
$49.60
Share price
-5.36%
Change (1 day)
20.02%
Change (1 year)
Categories
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.
Earnings for Otsuka Holdings (4578.T)
Earnings in 2024 (TTM): $0.97 Billion USD
According to Otsuka Holdings 's latest financial reports the company's current earnings are $14.47 Billion USD. In 2023 the company made an earning of $1.05 Billion USD a decrease over its 2022 earnings that were of $1.32 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Otsuka Holdings from 2010 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | $0.97 B | -6.93% |
| 2023 | $1.05 B | -20.82% |
| 2022 | $1.32 B | -13.04% |
| 2021 | $1.52 B | -19.69% |
| 2020 | $1.90 B | 13.78% |
| 2019 | $1.67 B | 52.13% |
| 2018 | $1.09 B | 11.32% |
| 2017 | $0.98 B | -36.26% |
| 2016 | $1.54 B | 31.64% |
| 2015 | $1.17 B | |
| 2013 | $2.44 B | 33.73% |
| 2012 | $1.82 B | -4.78% |
| 2011 | $1.92 B | 46.23% |
| 2010 | $1.31 B |